Venge P - Search Results

1

Respiratory symptoms, bronchial responsiveness, and cellular characteristics of induced sputum in elite swimmers.

Helenius IJ, Rytilä P, Metso T, Haahtela T, Venge P, Tikkanen HO. Helenius IJ, et al. Among authors: venge p. Allergy. 1998 Apr;53(4):346-52. doi: 10.1111/j.1398-9995.1998.tb03904.x. Allergy. 1998. PMID: 9574875

2

Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season.

Klementsson H, Svensson C, Andersson M, Venge P, Pipkorn U, Persson CG. Klementsson H, et al. Among authors: venge p. Clin Exp Allergy. 1991 Nov;21(6):705-10. doi: 10.1111/j.1365-2222.1991.tb03199.x. Clin Exp Allergy. 1991. PMID: 1777832 Clinical Trial.

3

Soluble markers of allergic inflammation.

Venge P. Venge P. Allergy. 1994 Jan;49(1):1-8. doi: 10.1111/j.1398-9995.1994.tb00765.x. Allergy. 1994. PMID: 8198234 Review. No abstract available.

4

Eosinophil peroxidase: a new serum marker of atopy and bronchial hyper-responsiveness.

Bjornsson E, Janson C, Hakansson L, Enander I, Venge P, Boman G. Bjornsson E, et al. Among authors: venge p. Respir Med. 1996 Jan;90(1):39-46. doi: 10.1016/s0954-6111(96)90243-7. Respir Med. 1996. PMID: 8857325 Free article.

5

The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X.

Pedersen B, Dahl R, Larsen BB, Venge P. Pedersen B, et al. Among authors: venge p. Allergy. 1993 Jul;48(5):377-82. doi: 10.1111/j.1398-9995.1993.tb02410.x. Allergy. 1993. PMID: 8103646 Clinical Trial.

6

Activation of blood coagulation during inhalation challenge tests.

Dahl R, Venge P. Dahl R, et al. Among authors: venge p. Allergy. 1981 Feb;36(2):129-33. doi: 10.1111/j.1398-9995.1981.tb04107.x. Allergy. 1981. PMID: 7235204

7

A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma.

Rak S, Heinrich C, Jacobsen L, Scheynius A, Venge P. Rak S, et al. Among authors: venge p. J Allergy Clin Immunol. 2001 Dec;108(6):921-8. doi: 10.1067/mai.2001.119743. J Allergy Clin Immunol. 2001. PMID: 11742269 Clinical Trial.

8

Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma.

Boner AL, Peroni DG, Piacentini GL, Venge P. Boner AL, et al. Among authors: venge p. Clin Exp Allergy. 1993 Dec;23(12):1021-6. doi: 10.1111/j.1365-2222.1993.tb00294.x. Clin Exp Allergy. 1993. PMID: 10779296

9

Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjögren's syndrome. BHR Study Group. Bronchial hyperresponsiveness.

Lúdvíksdóttir D, Janson C, Björnsson E, Stålenheim G, Boman G, Hedenström H, Venge P, Gudbjörnsson B, Valtysdóttir S. Lúdvíksdóttir D, et al. Among authors: venge p. Allergy. 2000 Mar;55(3):259-65. doi: 10.1034/j.1398-9995.2000.00252.x. Allergy. 2000. PMID: 10753017

10

Markers for eosinophils and T-lymphocytes as predictors of late asthmatic response.

Schmekel B, Venge P. Schmekel B, et al. Among authors: venge p. Allergy. 1993;48(17 Suppl):94-7; discussion 110-1. doi: 10.1111/j.1398-9995.1993.tb04708.x. Allergy. 1993. PMID: 8109720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results